These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 36183490)

  • 1. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
    Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
    Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
    Hollister J; Caban-Martinez AJ; Ellingson KD; Beitel S; Fowlkes AL; Lutrick K; Tyner HL; Naleway AL; Yoon SK; Gaglani M; Hunt D; Meece J; Mayo Lamberte J; Schaefer Solle N; Rose S; Dunnigan K; Khan SM; Kuntz JL; Fisher JM; Coleman A; Britton A; Thiese MS; Hegmann KT; Pavuk M; Ramadan FA; Fuller S; Nematollahi A; Sprissler R; Burgess JL
    Environ Res; 2023 Dec; 239(Pt 1):117297. PubMed ID: 37816422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-life exposure to perfluoroalkyl substances and serum antibody concentrations towards common childhood vaccines in 18-month-old children in the Odense Child Cohort.
    Sigvaldsen A; Højsager FD; Paarup HM; Beck IH; Timmermann CAG; Boye H; Nielsen F; Halldorsson TI; Nielsen C; Möller S; Barington T; Grandjean P; Jensen TK
    Environ Res; 2024 Feb; 242():117814. PubMed ID: 38042520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of COVID-19 and serum
    Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
    Glob Epidemiol; 2024 Jun; 7():100137. PubMed ID: 38293561
    [No Abstract]   [Full Text] [Related]  

  • 6. High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden.
    Andersson AG; Lundgren A; Xu Y; Nielsen C; Lindh CH; Pineda D; Cederlund J; Pataridou E; Søgaard Tøttenborg S; Ugelvig Petersen K; Fletcher T; Lagging M; Bemark M; Jakobsson K; Li Y
    Environ Health Perspect; 2023 Aug; 131(8):87007. PubMed ID: 37578904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of 3M Cordova, IL production worker's per- and polyfluoroalkyl substances biomonitoring results and mortality experience.
    Andres KL; Olsen GW; Krisko RM; Nunnally MC; Boeding RR; Leniek KL; Taiwo OA
    Int J Hyg Environ Health; 2024 Mar; 256():114321. PubMed ID: 38244249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between perfluoroalkyl substances concentration and bone mineral density in the US adolescents aged 12-19 years in NHANES 2005-2010.
    Xiong X; Chen B; Wang Z; Ma L; Li S; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():980608. PubMed ID: 36277702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
    Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
    Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.